636559-71-2Relevant academic research and scientific papers
Synthetic Routes toward Acidic Pentasaccharide Related to the O-Antigen of E. coli 120 Using One-Pot Sequential Glycosylation Reactions
Mukherjee, Mana Mohan,Ghosh, Rina
supporting information, p. 5751 - 5760 (2017/06/07)
Concise syntheses of the acidic pentasaccharide, related to the O-antigenic polysaccharide of Escherichia coli 120, as its p-methoxyphenyl glycoside, have been achieved using a one-pot sequential glycosylation technique. The glycosylations have been accom
Efficient synthesis of O-antigen fragments expressed by Burkholderia anthina by modular synthesis approach
Nilsson, Inga,Michalik, Dirk,Silipo, Alba,Molinaro, Antonio,Vogel, Christian
, p. 98 - 107 (2015/03/05)
To facilitate mapping of the interaction region of the O-chain of the lipopolysaccharide from Burkholderia anthina and of a lipopolysaccharide-specific monoclonal antibody, trisaccharide propyl α-l-rhamnopyranosyl-(1→2)-α-d-galactopyranosyl-(1→3)-α-l-rham
RSK INHIBITORS AND THERAPEUTIC USES THEREOF
-
, (2008/06/13)
The present invention is directed to novel compounds and compositions that have Rsk specific inhibitory activity. In addition, inhibition of Rsk by the present compounds has been discovered to halt the proliferation of cancer cell lines while having little effect on the proliferation rate of normal cells. Therefore, the present invention identifies Rsk as a target for therapeutic intervention in diseased states in which the disease or the symptoms can be ameliorated by inhibition of Rsk catalytic activity.
